Drugs in development

Find out which new treatments are likely to become available over the next year, especially through expanded access programmes.

Don’t rush to take one if it is the only drug you aren’t resistant to, and if you are otherwise in good health.

New drugs are being developed in existing and new drug classes, but most are only in early stages of development.

This includes new nukes, NNRTIs, PIs, CCR5 inhibitors and integrase inhibitors.

Maturation inhibitors are another potential new class. They should interfere with one of the last processes in the HIV life cycle and result in non-infectious virus being produced. These compounds are not available yet.

Keep up-to-date on research on new drugs and treatment strategies.

This website includes update on new drugs and new research.

i-Base jointly publishes a pipeline report on new research into HIV, hepatitis and TB drugs.